» Articles » PMID: 31729581

Neuropathic Pain in Patients with Charcot-Marie-Tooth Type 1A

Overview
Journal Neurol Sci
Specialty Neurology
Date 2019 Nov 16
PMID 31729581
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Only several studies analyzed the characteristics of neuropathic pain (NeP) more extensively in patients with Charcot-Marie-Tooth type 1A (CMT1A). Therefore, we sought to determine the frequency and features of NeP in CMT1A patients and to assess the association between NeP and sociodemographic and clinical characteristics of patients with CMT1A.

Methods: Our research included 51 genetically diagnosed CMT1A patients. The International Association for the Study of Pain (IASP) criteria were used for diagnosis of NeP. PainDETECT questionnaire (PD-Q) was used to assess NeP features. The Medical Research Council (MRC) Sum Score, CMT Neuropathy Score (CMTNS), Overall Neuropathy Limitation Scale (ONLS) score, and Beck Depression Inventory were also used.

Results: NeP was present in 15 (29.4%) patients with CMT1A. The average intensity of pain was 5.7 ± 2.2 out of 10. The most sensitive neuropathic symptoms were numbness, then tingling, and burning sensations, while the most specific symptom was allodynia. Patients with NeP more frequently reported pain in the back (p < 0.01) and the trunk (p < 0.05). Patients with NeP had more pronounced disability of the upper extremities and overall disability, as assessed by the ONLS score (p < 0.05). Depression was more frequent in patients with NeP compared with patients without NeP (66.7 to 13.9%, p < 0.01).

Conclusion: NeP was present in almost one-third of the patients with CMT1A and it was moderate on average. Presence of NeP was associated with worse functional disability and depression.

Citing Articles

Charcot-Marie-Tooth disease: from historical landmarks in Brazil to current care perspectives.

Boiteux Uchoa Cavalcanti E, Leal R, Junior W, Nascimento O Arq Neuropsiquiatr. 2023; 81(10):913-921.

PMID: 37611635 PMC: 10631856. DOI: 10.1055/s-0043-1770348.


An Elderly Woman with Complaints of Pain and Hearing Loss, Diagnosed with CMT1A with PMP22 Duplication.

Takegami N, Hamada M, Yamaguchi-Takegami N, Sakuishi K, Toda T Intern Med. 2023; 63(2):315-318.

PMID: 37225480 PMC: 10864091. DOI: 10.2169/internalmedicine.1883-23.


Possible Neuropathic Pain in Clinical Practice-Review on Selected Diagnostic Tools and Its Further Challenges.

Szewczyk A, Jamroz-Wisniewska A, Rejdak K Diagnostics (Basel). 2023; 13(1).

PMID: 36611400 PMC: 9818081. DOI: 10.3390/diagnostics13010108.


Challenges in Treating Charcot-Marie-Tooth Disease and Related Neuropathies: Current Management and Future Perspectives.

Pisciotta C, Saveri P, Pareyson D Brain Sci. 2021; 11(11).

PMID: 34827446 PMC: 8615778. DOI: 10.3390/brainsci11111447.


Prenatal genetic testing in 19 fetuses with corpus callosum abnormality.

She Q, Tang E, Peng C, Wang L, Wang D, Tan W J Clin Lab Anal. 2021; 35(11):e23971.

PMID: 34569664 PMC: 8605137. DOI: 10.1002/jcla.23971.


References
1.
Kleyweg R, van der Meche F, Schmitz P . Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve. 1991; 14(11):1103-9. DOI: 10.1002/mus.880141111. View

2.
Carter G, Jensen M, Galer B, Kraft G, Crabtree L, Beardsley R . Neuropathic pain in Charcot-Marie-Tooth disease. Arch Phys Med Rehabil. 1998; 79(12):1560-4. DOI: 10.1016/s0003-9993(98)90421-x. View

3.
Shy M, Blake J, Krajewski K, Fuerst D, Laura M, Hahn A . Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology. 2005; 64(7):1209-14. DOI: 10.1212/01.WNL.0000156517.00615.A3. View

4.
Abresch R, Carter G, Jensen M, Kilmer D . Assessment of pain and health-related quality of life in slowly progressive neuromuscular disease. Am J Hosp Palliat Care. 2002; 19(1):39-48. DOI: 10.1177/104990910201900109. View

5.
Argoff C . The coexistence of neuropathic pain, sleep, and psychiatric disorders: a novel treatment approach. Clin J Pain. 2007; 23(1):15-22. DOI: 10.1097/01.ajp.0000210945.27052.b3. View